Catalysts for Xbrane Biopharma AB
5 tracked
Apr 30, 2026
filing
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→
Apr 30, 2026
filing
Xbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))
ranibizumab biosimilar
→